Your browser doesn't support javascript.
loading
A library approach for the de novo high-throughput isolation of humanized VHH domains with favorable developability properties following camelid immunization.
Arras, Paul; Yoo, Han Byul; Pekar, Lukas; Schröter, Christian; Clarke, Thomas; Krah, Simon; Klewinghaus, Daniel; Siegmund, Vanessa; Evers, Andreas; Zielonka, Stefan.
Afiliação
  • Arras P; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.
  • Yoo HB; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.
  • Pekar L; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.
  • Schröter C; Early Protein Supply & Characterization, Merck Healthcare KGaA, Darmstadt, Germany.
  • Clarke T; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.
  • Krah S; ADCs & Targeted NBE Therapeutics, Merck KGaA, Darmstadt, Germany.
  • Klewinghaus D; Bioinformatics, EMD Serono, Billerica, MA, USA.
  • Siegmund V; Antibody Discovery & Protein Engineering, Merck Healthcare KGaA, Darmstadt, Germany.
  • Evers A; Early Protein Supply & Characterization, Merck Healthcare KGaA, Darmstadt, Germany.
  • Zielonka S; Early Protein Supply & Characterization, Merck Healthcare KGaA, Darmstadt, Germany.
MAbs ; 15(1): 2261149, 2023.
Article em En | MEDLINE | ID: mdl-37766540
In this study, we generated a novel library approach for high throughput de novo identification of humanized single-domain antibodies following camelid immunization. To achieve this, VHH-derived complementarity-determining regions-3 (CDR3s) obtained from an immunized llama (Lama glama) were grafted onto humanized VHH backbones comprising moderately sequence-diversified CDR1 and CDR2 regions similar to natural immunized and naïve antibody repertoires. Importantly, these CDRs were tailored toward favorable in silico developability properties, by considering human-likeness as well as excluding potential sequence liabilities and predicted immunogenic motifs. Target-specific humanized single-domain antibodies (sdAbs) were readily obtained by yeast surface display. We demonstrate that, by exploiting this approach, high affinity sdAbs with an optimized in silico developability profile can be generated. These sdAbs display favorable biophysical, biochemical, and functional attributes and do not require any further sequence optimization. This approach is generally applicable to any antigen upon camelid immunization and has the potential to significantly accelerate candidate selection and reduce risks and attrition rates in sdAb development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos de Domínio Único Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article